A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

Clinical trial NCT03872947 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03872947
Sponsor: Toray Industries, Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Colorectal Cancer Cholangiocarcinoma Bladder Cancer Ovarian Cancer Gastric Cancer Palpable Subcutaneous Malignant Lesions Renal Cell Carcinoma Melanoma Epithelial Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer

Start date: 2019-04-26
Primary completion: 2026-06-01
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.